A Study of HW243040 in Healthy Participants

Inclusion criteria

• Informed consent must be obtained/signed prior to trial participation.
• Aged between 18 and 55 years old, both healthy males and females are eligible.
• Female participates must have a body weight of ≥ 45 kg and male participates ≥ 50 kg, with a body mass index (BMI) ranging from 19 to 26 kg/m^2.

Exclusion criteria

• History or presence of any clinically severe disorders of urinary, cardiovascular, endocrine, nervous, gastrointestinal, respiratory, hematologic, immune systems, psychiatric illnesses or metabolic abnormalities; or other conditions judged by the Investigator to confound trial outcomes, e.g., intestinal diseases (irritable bowel syndrome), urinary tract infections.
• History of malignant tumors (except for cancer with confirmed cure or remission for ≥5 years, radically resected basal or squamous cell skin cancer, carcinoma in situ of the cervix, and resected colonic polyps).
• Any conditions or diseases that, in the Investigator's judgment, may affect the absorption, metabolism and/or excretion of the investigational product.
• History of drug abuse or dependence.
• Hypersensitivity to any ingredient of the study drug，or history of allergic disorders or allergic diathesis.
• Any other condition that, in the opinion of the investigator, renders the participant unsuitable to participate in the study.